Literature DB >> 23801036

Bacterial meningitis in older adults.

Diedre Hofinger1, Larry E Davis.   

Abstract

OPINION STATEMENT: The burden of disease due to bacterial meningitis is shifting toward older adults. Clinicians should maintain a high level of suspicion of meningitis in older adults, since they may present without classic signs and symptoms. Clinicians should remember that more older patients are at risk of healthcare-associated meningitis and may be at risk of more resistant organisms. A lumbar puncture should be performed as quickly as possible. If a CT scan is required before the lumbar puncture, blood cultures should be drawn and appropriate empiric antibiotics should be started before sending the patient to the CT scanner. Empiric antibiotics should be chosen based on patient history, review of patient's known illnesses and risk factors, results of CSF Gram stain, and local institution antibiotic resistance patterns. Clinicians should remember that Streptococcus pneumoniae may be resistant to penicillin and cephalosporins, so vancomycin is usually also administered until the bacterial resistance pattern is known. Adjunctive dexamethasone may be started before or at the time of antibiotic therapy based on risk versus benefit analysis, and may be discontinued if patient is found to not have Streptococcus pneumoniae meningitis.

Entities:  

Year:  2013        PMID: 23801036     DOI: 10.1007/s11940-013-0244-7

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  76 in total

1.  Uncloaking the meningococcus: dynamics of carriage and disease.

Authors:  D S Stephens
Journal:  Lancet       Date:  1999-03-20       Impact factor: 79.321

2.  Gram-negative bacillary meningitis in adult post-neurosurgical patients.

Authors:  C H Lu; W N Chang; Y C Chuang; H W Chang
Journal:  Surg Neurol       Date:  1999-11

3.  Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study.

Authors:  Jean-Damien Ricard; Michel Wolff; Jean-Claude Lacherade; Bruno Mourvillier; Nadia Hidri; Guilène Barnaud; Guillaume Chevrel; Lila Bouadma; Didier Dreyfuss
Journal:  Clin Infect Dis       Date:  2006-12-15       Impact factor: 9.079

4.  The prognostic factors of adult gram-negative bacillary meningitis.

Authors:  C H Lu; W N Chang; Y C Chuang; H W Chang
Journal:  J Hosp Infect       Date:  1998-09       Impact factor: 3.926

5.  Managing meningococcal disease in the United States: Hospital case characteristics and costs by age.

Authors:  Judith A O'Brien; J Jaime Caro; Denis Getsios
Journal:  Value Health       Date:  2006 Jul-Aug       Impact factor: 5.725

Review 6.  Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence.

Authors:  Matthew E Falagas; Ioannis A Bliziotis; Vincent H Tam
Journal:  Int J Antimicrob Agents       Date:  2006-11-28       Impact factor: 5.283

Review 7.  Corticosteroids for acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Peter McIntyre; Jan de Gans; Kameshwar Prasad; Diederik van de Beek
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

Review 8.  Cefepime neurotoxicity: case report, pharmacokinetic considerations, and literature review.

Authors:  Sum Lam; Irving H Gomolin
Journal:  Pharmacotherapy       Date:  2006-08       Impact factor: 4.705

9.  Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial.

Authors:  E M Molyneux; A L Walsh; H Forsyth; M Tembo; J Mwenechanya; K Kayira; L Bwanaisa; A Njobvu; S Rogerson; G Malenga
Journal:  Lancet       Date:  2002-07-20       Impact factor: 79.321

10.  Effects of new penicillin susceptibility breakpoints for Streptococcus pneumoniae--United States, 2006-2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-12-19       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.